These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

167 related items for PubMed ID: 6124875

  • 1. Discrimination of three opiate receptor binding sites with the use of a computerized curve-fitting technique.
    Pfeiffer A, Herz A.
    Mol Pharmacol; 1982 Mar; 21(2):266-71. PubMed ID: 6124875
    [Abstract] [Full Text] [Related]

  • 2. Further demonstration of kappa opioid binding sites in the brain: evidence for heterogeneity.
    Su TP.
    J Pharmacol Exp Ther; 1985 Jan; 232(1):144-8. PubMed ID: 2856939
    [Abstract] [Full Text] [Related]

  • 3. Discrimination of three types of opioid binding sites in rat brain in vivo.
    Rosenbaum JS, Holford NH, Richards ML, Aman RA, Sadée W.
    Mol Pharmacol; 1984 Mar; 25(2):242-8. PubMed ID: 6321946
    [Abstract] [Full Text] [Related]

  • 4. Heterogeneity of opioid receptor binding in brain slices.
    Barchfeld-Rothschild CC, Medzihradsky F.
    J Neurosci Res; 1987 Mar; 18(2):358-65. PubMed ID: 2891857
    [Abstract] [Full Text] [Related]

  • 5. Solubilization and preliminary characterization of mu and kappa opiate receptor subtypes from rat brain.
    Chow T, Zukin RS.
    Mol Pharmacol; 1983 Sep; 24(2):203-12. PubMed ID: 6310362
    [Abstract] [Full Text] [Related]

  • 6. Differentiating aspects of opioid receptor binding by [3H](-) (1R,5R,9R,2''S)-5,9-dimethyl-2-tetrahydrofurfuryl-2'-hydroxy-6,7- benzomorphan hydrochloride ([3H]Mr 2034), a drug preferentially acting on kappa-receptors.
    Ensinger HA.
    Arzneimittelforschung; 1985 Sep; 35(1A):447-51. PubMed ID: 2985096
    [Abstract] [Full Text] [Related]

  • 7. Opiate receptor subtypes in the rat hypothalamus and neurointermediate lobe.
    Stojilković SS, Dufau ML, Catt KJ.
    Endocrinology; 1987 Jul; 121(1):384-94. PubMed ID: 3036471
    [Abstract] [Full Text] [Related]

  • 8. The binding to rat brain homogenates of Mr2034, a universal opiate.
    Johnson N, Pasternak GW.
    Life Sci; 1983 Sep 05; 33(10):985-91. PubMed ID: 6310291
    [Abstract] [Full Text] [Related]

  • 9. Multiple opiate binding sites in the central nervous system of the rabbit. Large predominance of a mu subtype in the cerebellum and characterization of a kappa subtype in the thalamus.
    Meunier JC, Kouakou Y, Puget A, Moisand C.
    Mol Pharmacol; 1983 Jul 05; 24(1):23-9. PubMed ID: 6306437
    [Abstract] [Full Text] [Related]

  • 10. Evidence for multiple "Kappa" binding sites by use of opioid peptides in the guinea-pig lumbo-sacral spinal cord.
    Attali B, Gouardères C, Mazarguil H, Audigier Y, Cros J.
    Neuropeptides; 1982 Oct 05; 3(1):53-64. PubMed ID: 6296719
    [Abstract] [Full Text] [Related]

  • 11. [3H]Ethylketocyclazocine binding to mouse brain membranes: evidence for a kappa opioid receptor type.
    Garzón J, Sánchez-Blázquez P, Lee NM.
    J Pharmacol Exp Ther; 1984 Oct 05; 231(1):33-7. PubMed ID: 6092603
    [Abstract] [Full Text] [Related]

  • 12. The binding of kappa- and sigma-opiates in rat brain.
    Wolozin BL, Nishimura S, Pasternak GW.
    J Neurosci; 1982 Jun 05; 2(6):708-13. PubMed ID: 6283040
    [Abstract] [Full Text] [Related]

  • 13. Different types of opiate agonists interact distinguishably with mu, delta and kappa opiate binding sites.
    Pfeiffer A, Herz A.
    Life Sci; 1982 Jun 05; 31(12-13):1355-8. PubMed ID: 6128658
    [Abstract] [Full Text] [Related]

  • 14. Biochemical characterization of high-affinity 3H-opioid binding. Further evidence for Mu1 sites.
    Nishimura SL, Recht LD, Pasternak GW.
    Mol Pharmacol; 1984 Jan 05; 25(1):29-37. PubMed ID: 6323950
    [Abstract] [Full Text] [Related]

  • 15. Opioid receptors of bovine posterior pituitary neurosecretosomes are exclusively kappa.
    Pesce GO, Lang MA, Cruciani RA, Russell JT, Gainer H, Rodbard D.
    NIDA Res Monogr; 1986 Jan 05; 75():77-80. PubMed ID: 2893283
    [Abstract] [Full Text] [Related]

  • 16. Characterization of the kappa-subtype of the opiate receptor in the guinea-pig brain.
    Kosterlitz HW, Paterson SJ, Robson LE.
    Br J Pharmacol; 1981 Aug 05; 73(4):939-49. PubMed ID: 6268235
    [Abstract] [Full Text] [Related]

  • 17. Adrenal medullary opiate receptors. Pharmacological characterization in bovine adrenal medulla and a human pheochromocytoma.
    Castanas E, Giraud P, Audigier Y, Drissi R, Boudouresque F, Conte-Devolx B, Oliver C.
    Mol Pharmacol; 1984 Jan 05; 25(1):38-45. PubMed ID: 6323951
    [Abstract] [Full Text] [Related]

  • 18. Site-directed alkylation of multiple opioid receptors. I. Binding selectivity.
    James IF, Goldstein A.
    Mol Pharmacol; 1984 May 05; 25(3):337-42. PubMed ID: 6328259
    [Abstract] [Full Text] [Related]

  • 19. Preparation of brain membranes containing a single type of opioid receptor highly selective for dynorphin.
    James IF, Chavkin C, Goldstein A.
    Proc Natl Acad Sci U S A; 1982 Dec 05; 79(23):7570-4. PubMed ID: 6130527
    [Abstract] [Full Text] [Related]

  • 20. Characterization of specific binding sites for [3H](d)-N-allylnormetazocine in rat brain membranes.
    Itzhak Y, Hiller JM, Simon EJ.
    Mol Pharmacol; 1985 Jan 05; 27(1):46-52. PubMed ID: 3965930
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.